Table 1.
Antibiotic susceptibilities of Escherichia coli JN05 and its transconjugant.
| Minimal inhibitory concentrations (μg/mL) |
|||||||||||||||||
| Isolates | TZP | ATM | CZO | CRO | CAZ | FEP | FOX | IMP | MEM | ETP | AK | CN | CIP | LEV | SXT | FOS | TGC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JN05 | > = 256 | > = 256 | > = 256 | > = 256 | > = 256 | > = 256 | > = 256 | > = 32 | > = 32 | > = 32 | > = 256 | > = 256 | > = 32 | > = 32 | > = 32 | 2 | 0.38 |
| J05 | > = 256 | 0.64 | > = 256 | > = 256 | > = 256 | 16 | > = 256 | 16 | 8 | 12 | 1 | 0.5 | < = 0.02 | < = 0.02 | 0.32 | 2 | 0.38 |
| J53AziR | < = 0.016 | < = 0.016 | < = 0.016 | < = 0.016 | < = 0.016 | < = 0.016 | < = 0.016 | < = 0.02 | < = 0.02 | < = 0.02 | < = 0.016 | < = 0.016 | < = 0.02 | < = 0.02 | < = 0.02 | 2 | 0.38 |
TZP, piperacillin/tazobactam; ATM, aztreonam; CZO, cefazolin; CRO, cefatriaxone; FEP, cefepime; FOX,cefoxitin; IPM, imipenem; MEM, meropenem; ETP, ertapenem; AK, amikacin; CN,gentamicin; CIP, ciprfloxacin; LEV,levofloxacin; STX, trimethoprim/sulfamethoxazole; FOS, fosfomycin; and TGC, tigecycline.